Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Honeywell Aerospace began independent trading on June 29, 2026 with a broad installed base, recurring aftermarket exposure and strong demand indicators. Second-quarter backlog reached $18.154 billion, up 9% year over year, while trailing-twelve-month orders rose 8%. However, supply constraints limited output, adjusted EBIT declined 7%, and management reduced 2026 organic-growth guidance from 7%-9% to 4%-5% and adjusted-EBIT guidance from $4.65-$4.75 billion to $4.35-$4.45 billion. The resulting balance of durable demand and elevated execution risk supports a Hold pending evidence that supplier actions restore output and stabilize profitability.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets13 analysts · as of 18 Aug 2026
Low · most bearish analyst$175.00
Mean target$225.31
High · most bullish analyst$306.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$175.0020%

Supply constraints, unfavorable mix and higher costs persist, causing organic growth or adjusted EBIT to fall below revised guidance. Weak conversion of the demand backlog and continued separation-related disruption delay the expected operational recovery.

Base CaseCentral scenario
$225.3156%
Matches the consensus mean

Demand remains healthy, supported by backlog and aftermarket activity, while supply constraints improve only gradually. Full-year organic growth and adjusted EBIT remain within the revised guidance ranges, with progress toward stronger execution in 2027.

Bull CaseUpside scenario
$306.0024%

Supplier qualification, additional tooling and expanded multi-sourcing improve output during the second half. Backlog converts efficiently, organic growth reaches the top of the 4%-5% range, and adjusted EBIT reaches the upper end of $4.35-$4.45 billion.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter backlog was $18.154 billion, 9% above the prior year, and trailing-twelve-month orders increased 8%, indicating substantial underlying demand.
  • Commercial Aftermarket sales rose 8% year over year to $2.026 billion, providing exposure to recurring demand across the installed base.
  • The company reported $15 billion of year-to-date new wins and is expanding supplier qualification, tooling investment and multi-sourcing to support future growth.
Sign in / Sign up to read more
Key Investment Risks
  • Management reduced 2026 organic-growth guidance to 4%-5% from 7%-9%, explicitly aligning the outlook with demonstrated supply-chain capacity.
  • Second-quarter adjusted EBIT declined 7% despite 5% organic sales growth, reflecting separation-related costs, inventory charges, mix and other cost pressures.
  • As a newly independent company, Honeywell Aerospace must establish standalone systems and execute its operating model while managing supply-chain constraints and separation effects.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.